Grace Therapeutics, Inc. (GRCE)

Working Capital Ratio

26.13%

Quarterly · Period ending:

GRCE logo

GRCE Working Capital Ratio

Latest reported22.86%
GRCE FY Working Capital Ratio (-378.58% → 22.86%)
High-resolution chart · PNG

GRCE working capital ratio history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Grace Therapeutics, Inc. Working Capital Ratio — Annual fiscal periods
Period endingWorking Capital Ratio
22.8553%
28.8667%
30.4584%
32.7073%
32.865%
97.3342%
37.4699%
38.7522%
12.1739%
31.6193%
35.712%
48.43%
54.0102%
28.0462%
48.2994%
-16.9467%
-45.1204%
-378.5766%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.